SPECIAL REPORT on Aducanumab Approval: A Pulitzer Prize-winning Journalist's Perspective
Release Date: 06/24/2021
Psychogenic Nonepileptic Seizures in Children and Adolescents; Part 1 of the Thunderclap Headache Series
Neurology® Podcast
In the first segment, Dr. Jon Stone talks with Dr. Anne Sofie Hansen about the spectrum and risk of psychiatric disorders in childhood-onset psychogenic nonepileptic seizures. In the second part of the podcast, Dr. Teshamae Monteith discusses ten causes of thunderclap headache and presentation with Dr. Alexandra Cocores in the first part of our four-part series on thunderclap headache.
info_outline
Perspectives on Aducanumab Approval (Neurology Recall August 2021)
Neurology® Podcast
This month’s replay of past episodes showcases a selection of interviews concerning the FDA approval of aducanumab for the treatment of Alzheimer disease from clinical, political, and economic perspectives. The selected interviews feature conversations between Dr. Gregg Day and Pam Belluck, Dr. Jeff Burns and Dr. Ron Peterson, Dr. Jason Crowell and Dr. Steve Pearson, and Dr. Jeff Burns and Dr. Daniel Gibbs.
info_outline
Impact of Thymectomy on Myasthenia Gravis Remission
Neurology® Podcast
Dr. Stacey Clardy discusses the impact of surgical approaches to thymectomy upon remission rates in myasthenia gravis with Dr. Joseph Shrager.
info_outline
Symptoms and Incidence of RCVS; Optimizing Stroke Prevention in Atrial Fibrillation
Neurology® Podcast
In the first segment, Will Rondeau discusses the symptoms, incidence, and resource utilization of reversible cerebrovascular vasoconstriction syndrome with Dr. Jessica Magid-Bernstein. In the second part of the podcast, Dr. Andy Southerland discusses the optimization of atrial fibrillation treatment and stroke prevention with Dr. Seemant Chaturvedi.
info_outline
Illness in Overseas U.S. Embassies Employees; Afferent Baroreflex Failure
Neurology® Podcast
In the first segment, Dr. Alex Menze talks with Dr. Clifford Saper about Havana Syndrome and recent attacks on American diplomats. In the second part of the podcast, Dr. Jeff Ratliff discusses the natural history of afferent baroreflex failure with Dr. Guillaume Lamotte.
info_outline
Evaluations in First Episode Psychosis; Dr. Daniel Gibbs on his Battle with Alzheimer's
Neurology® Podcast
In the first segment, Dr. Gregg Day speaks with Dr. Josep Dalmau about NMDAR antibodies in patients with first episode psychosis and the utility of criteria for autoimmune psychosis. In the second part of the podcast, Dr. Jeff Burns talks to neurologist Dr. Daniel Gibbs about his Alzheimer’s disease diagnosis and experience participating in a clinical trial for aducanumab.
info_outline
Management of Neurologic Conditions in Pregnancy (Neurology Recall July 2021)
Neurology® Podcast
This month's replay of past episodes showcases a selection of interviews on the impact of pregnancy on various neurologic disorders, featuring Drs. Page Pennell, Paula Emanuela Voinescu, Mary Angela O'Neal, Emma Ciafaloni, Raed Alroughani, Rae Bacharach, Annette Langer-Gould, Nicolas Collongues, and Petra Ijäs.
info_outline
SPECIAL REPORT: A Discussion with Mary Post (Part 2)
Neurology® Podcast
This second installment in our two-part series features Dr. Stacey Clardy in conversation with Mary Post, CEO of the American Academy of Neurology.
info_outline
SPECIAL REPORT on Aducanumab Approval: A Pulitzer Prize-winning Journalist's Perspective
Neurology® Podcast
Dr. Gregg Day speaks with Pam Belluck, an award-winning journalist at the New York Times, about her coverage of the recent FDA approval of aducanumab for Alzheimer disease treatment.
info_outline
SPECIAL REPORT: A Discussion With Mary Post (Part 1)
Neurology® Podcast
This first installment of a 2-part series features Dr. Stacey Clardy in conversation with Mary Post, CEO of the American Academy of Neurology.
info_outlineDr. Gregg Day speaks with Pam Belluck, an award-winning journalist at the New York Times, about her coverage of the recent FDA approval of aducanumab for Alzheimer disease treatment.